Free Psychiatry CME

  • FREE

    Healio Free Psychiatry CME

    Find out what over 50,000 of your colleagues already know. Earn credits faster and easier with Healio CME.

    See full details chevron_right
    • Cost: Free
  • FREE

    ScientiaCME Neuropsychiatry – Psychiatry

    • Cost: Free
    • Credit hours: 2
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Expiration of CME credit: Two years after release
  • FREE

    CME: Addressing barriers to optimal care in schizophrenia with pharmacotherapy

    Activity Description / Statement of Need:

    Schizophrenia is a mental health disorder characterized by disrupted neurochemical pathways, thought processes, emotions, and social interactions. While schizophrenia is a heterogeneous disease both across and within patients, it is nonetheless a debilitating disorder for many individuals. An estimated 0.25% to 0.75% of the population suffer from schizophrenia, resulting in about 20.9 million cases and 13.4 million years of life lived with disability worldwide. The goals of treatment for schizophrenia should include not only reducing the number of acute psychotic episodes and reducing the risk for future relapse but also improving quality of life and function beyond symptom relief, such as outcomes related to school, work, and relationships. To achieve these goals, a combination of pharmacologic and non-pharmacologic interventions are recommended. Although current guidelines are explicit about the importance of engaging patients in goal setting and valuing patient preferences, psychiatrists not uncommonly undervalue the importance of improving daily living and capacity for work, suggesting an important practice gap.

    Target Audience:

    Psychiatrists and primary care physicians; nurse practitioners, physician assistants, and pharmacists who specialize in psychiatry; and those who otherwise commonly care for or clinically encounter patients who have schizophrenia.

    By the end of the session the participant will be able to:

    • Describe challenges to the successful management of schizophrenia relating to treatment adherence and develop corresponding solutions.
    • Prioritize agents from both first- and second-generation antipsychotics, given a patient case and using patient-centered decision-making.
    • Describe the ways in which understanding of schizophrenia neuropathology has changed and pair that knowledge with treatment mechanisms.
    • List present and emerging treatment options for schizophrenia, including those targeted at negative symptoms and apply them to patient cases using evidence-based medicine.
    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 11/27/2020
    • Expiration of CME credit: 11/27/2022
  • FREE

    Bipolar and mood disorder: Therapeutic updates and best practices

    Activity Description / Statement of Need:

    In this online CME self-learning activity:

    Bipolar disorder is a mood disorder characterized by episodes of mania, hypomania, and depression. It affects 3-4% of the U.S. population, represents a substantial societal and economic burden in the United States, is also found to be strongly associated with other major public health concerns like diabetes and cardiovascular disease as well as suicide.

    The literature demonstrates that medication nonadherence is a major issue among patients with bipolar disorder. Nonadherence affects approximately 60% of patients and can result in hospitalization, poor effectiveness, increased relapses, and increased risk of morbidity. Other factors, such as patient perceptions, illness severity, and the relationship between the physician and patient, come into play and should be taken into account to optimize adherence.

    Target Audience:

    Healthcare professionals specializing in: family medicine, internal medicine, mental health, neurology and psychiatry, or those who otherwise commonly care for patients with bipolar or related psychiatric diseases.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 09/11/2020
    • Expiration of CME credit: 09/11/2022
  • FREE

    Updates in alcohol use disorder (AUD) pharmacotherapy and barriers to optimal care

    In this online CME self-learning program: Alcohol use disorder (AUD), referred to colloquially as alcoholism, is an integration of past terms that have include in past as alcohol dependence or abuse, and may be marked by any one of a number of different symptoms or behaviors that include physical cravings, compulsion, guilt, and frequent consumption over an extended period of time. A quarter of adults report at least one day of heavy drinking over the past year. Alcohol accounts for over 687,000 emergency department visits in the U.S. by people under age 20 per year; worldwide, 76.3 million people are estimated to have AUDs, and they account for an annual mortality rate of 1.8 million. AUD is largely under-recognized and undertreated, constituting one gap in care and justifying continuing HCP education. HCPs are considered well-positioned to be able to recognize AUD, and one of the first missed opportunities to do so is failing to employ a validated screening tool, which might identify a condition well before it reaches the full scale of its adverse psychosocial potential.

    Target Audience:

    HCPs who are: psychiatrists, primary care physicians, emergency medicine physicians, physician assistants, nurse practitioners, pharmacists, and those who otherwise commonly treat patients suffering from or have a clinical interest in AUD.

    By the end of the session the participant will be able to:

    • Describe the common clinical presentation(s) of AUD.
    • Recall recommended AUD diagnostic criteria, and apply them to a patient case.
    • List current treatment options for AUD, including behavioral and pharmacologic therapies and apply them to patient cases using evidence-based medicine.
    • Describe challenges to the successful management of AUD relating to treatment adherence.
    • See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 09/25/2020
    • Expiration of CME credit: 09/25/2022
  • FREE

    Free Psychiatry CME Courses from Pri-Med® – Designed for Primary Care Clinicians

    Individuals with depression, anxiety, bipolar disorder, and other psychiatric conditions first seek help from primary care providers like you. Our courses offer practical guidance on assessing and managing these can’t-miss diagnoses in your patients. Choose from a variety of free psychiatry CME courses to improve care for your patients. Earn credits at no cost today.

    See full details chevron_right
    • Cost: Free
    • Credit hours: Varies by Course
    • CME credits awarded by: pmiCME, the accredited division of Pri-Med®
    • Format: On-Demand Courses Online
    • Material last updated: Continuously Updated
    • Expiration of CME credit: Varies by Course
  • FREE

    CME: Improving the treatment and management of schizophrenia: an overview of current and novel approaches

    Schizophrenia, by nature, presents manifold challenges to the HCP directing neuropsychiatric care. Not only do practical matters like medication adherence play a role in the success of therapy, but it behooves clinicians to also have a well-informed understanding of the symptomatology and treatment course of the disease. Atypical antipsychotics are the mainstay of initial pharmacotherapy, with oral agents being preferred first. However, they have sometimes been associated with poor patient adherence, which is associated with suboptimal clinical outcomes. In contrast, improving adherence may enhance quality of life and reduce the risk of hospitalization, thereby potentially lowering health resource utilization and its associated costs.

    By the end of the session the participant will be able to:

    • Describe the pathophysiology of schizophrenia and the role the neurotransmitters receptors play in it: D2, D3, 5-HT2A
    • Describe the benefits and risks of pharmacotherapy for schizophrenia and take them into account when formulating a treatment plan for different patients
    • Formulate a treatment plan for a variety of patients with schizophrenia, including those exhibiting only negative symptoms
    • Recommend therapy changes in patients who are unable to tolerate a prescribed treatment
    • Identify barriers to care in patients with schizophrenia and develop** strategies to abate them

    Target Audience:

    Healthcare professionals who are: psychiatrists and primary care physicians; nurse practitioners, physician assistants, nurses, and pharmacists who specialize in psychiatry; and those who otherwise commonly care for or clinically encounter patients who have schizophrenia.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 3/6/2020
    • Expiration of CME credit: 3/6/2022
  • FREE

    CME: Opioid dependence and opioid use disorder: best practices, barriers in care, and the role of long-acting injectable medication

    Opioid use disorder (OUD) affects millions of individuals globally and is best defined by the Diagnostic and Statistic Manual of Mental Disorders, Fifth Edition (DSM-5) as a condition due to tolerance, manifestation of physical dependence, and loss of control leading to health hazards.The scale of the problem is staggering, and while the causes are manifold, it is fueled in part by widespread availability: the Centers for Disease Control and Prevention estimates that the distribution of prescription opioid analgesics rose over fivefold between 1997 and 2007.

    By the end of the session the participant will be able to:

    • Describe the epidemiology of OUD and dependence, and outline current and the significance of inappropriate selection and treatment of opioid therapy
    • Identify long-acting treatment modalities for OUD and dependence, and apply them to patient cases using evidence-based medicine
    • Identify challenges associated with the selection and implementation of drug regimens to the treatment of OUD and dependence, including risk factors for opioid overdose
    • Develop strategies for recognizing and improving therapeutic adherence in patients treated for OUD and opioid dependence

    Target Audience:

    Healthcare professionals specializing in: addiction specialists, pain management specialists, primary care physicians, and psychiatrists; physician assistants, nurse practitioners, nurses, and pharmacists who practice in pain management or substance abuse; and any other health professionals who encounter OUD in the clinical setting.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 12/30/19
    • Expiration of CME credit: 12/30/21